Table 2.
Operative data of patients with reference to PCC administration
| Overall series | Propensity score–matched pairs | |||||||
|---|---|---|---|---|---|---|---|---|
| No PCC (n = 680) | PCC (n = 291) | p Value | Pre-match SD | No PCC (n = 225) | PCC (n = 225) | p Value | Post-match SD | |
| Type of surgery | 0.009 | 0.901 | ||||||
| Isolated CABG | 173 (25.4) | 47 (16.2) | 0.228 | 39 (17.3) | 36 (16.0) | 0.035 | ||
| Isolated valve surgery | 226 (33.2) | 113 (38.8) | 0.117 | 92 (40.9) | 88 (39.1) | 0.037 | ||
| Valve surgery + CABG | 154 (22.6) | 64 (22.0) | 0.014 | 47 (20.9) | 53 (23.6) | 0.065 | ||
| Aortic surgery | 127 (18.7) | 67 (23.0) | 0.106 | 47 (20.9) | 48 (21.3) | 0.01 | ||
| CPB time, min | 152 ± 64 | 148 ± 64 | 0.234 | 0.001 | 150 ± 65 | 152 ± 68 | 0.734 | 0.001 |
| ACC time, min | 111 ± 51 | 106 ± 49 | 0.157 | 0.002 | 104 ± 46 | 109 ± 50 | 0.410 | 0.002 |
| Nadir Hct during CPB, % | 22.9 ± 3.9 | 23.9 ± 3.6 | <0.0001 | 0.071 | 23.4 ± 4.3 | 23.7 ± 3.7 | 0.305 | 0.019 |
ACC aortic cross-clamp, CABG coronary artery bypass graft, CPB cardiopulmonary bypass, Hct haematocrit, PCC prothrombin complex concentrates, SD standard deviation
Continuous values are reported as mean and standard deviation; nominal variables are reported as counts and (percentages)